A porous structure polyacrylic acid drug-loaded embolic microsphere and its preparation method

By preparing porous structure polyacrylic acid drug-loading embolization microspheres, the problems of low drug loading and fast drug release speed are solved, and the slow release and high-efficiency drug loading are achieved, ensuring the uniformity of the shape of the microspheres and the controllability of the particle size of the microspheres are achieved. , significantly improve the therapeutic effect.

CN116270488BActive Publication Date: 2024-11-01SICHUAN DACHUAN HEYI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310283772.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-22
Publication Date
2024-11-01
Estimated Expiration
2043-03-22

AI Technical Summary

Technical Problem

The existing drug-loading microspheres have problems such as low drug loading, fast drug release speed, uneven size and easy tube blockage, and the drug desorption and blast release are serious, which affects the treatment effect.

Method used

The preparation method of porous structure polyacrylic acid drug-loaded embolization microspheres is adopted. By dissolving acrylic or polyacrylic acid, initiator, crosslinking agent and pore-generating agent in water, an internal phase solution is formed and dissolved with the surfactant in the oil phase. Droplets are made through a microfluidic control device, cross-linked in the oil phase, forming porous structured microspheres, increasing the specific surface area and -COOH groups, and improving the drug loading and drug binding ability.

Benefits of technology

It achieves rapid loading and slow release of drugs, increases drug loading volume, reduces drug desorption and explosive release, ensures uniform shape and controllable particle size of microspheres, and enhances the therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116270488B_ABST
    Figure CN116270488B_ABST
Patent Text Reader

Abstract

The invention discloses a porous polyacrylic acid drug-loaded embolic microsphere and a preparation method thereof, and relates to the technical field of interventional treatment materials. The preparation method comprises the following steps: a. dissolving acrylic acid or polyacrylic acid, an initiator, a crosslinking agent and a porogen in water to obtain an inner phase solution; b. dissolving a surfactant in an oil phase to obtain an outer phase solution; c. preparing acrylic acid or polyacrylic acid droplets through a microfluidic device through the inner phase solution in step a and the outer phase solution in step b, and then sending the droplets to an oil phase at 55-110 DEG C for crosslinking, and removing the upper oil phase solution after the crosslinking is completed to obtain a primary microsphere; d. washing and drying the primary microsphere in step c to obtain a porous polyacrylic acid drug-loaded embolic microsphere with a high drug loading amount, wherein the microsphere has a regular morphology and a uniform size, is not prone to desorption and burst release after drug loading, and has the advantage of fast drug loading speed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of interventional treatment materials, and in particular to a porous polyacrylic acid drug-loaded embolic microsphere and a preparation method thereof. Background Art

[0002] According to data from the National Cancer Center, the incidence and mortality of malignant tumors in my country continue to rise, and the annual medical expenses caused by malignant tumors exceed 220 billion. With the aging of the population, it is expected that the cancer burden will increase by 50% in 2040 compared with 2020. In recent years, with the rapid development of tumor treatment medical technology, in addition to the three standard treatments of surgery, radiotherapy and chemotherapy, new treatment methods such as microwave ablation, radioactive particle implantation and microsphere embolization have also been introduced into the field of tumor treatment. Among them, embolization therapy is based on transcatheter chemoembolization. By injecting embolic agents into the arteries near tumor cells, the arterial blood supply channel is blocked, and blood and nutrients cannot be supplied to cancer cells, causing them to "starve to death", thereby achieving the purpose of tumor treatment.

[0003] As a common embolic agent, embolic microspheres can be divided into blank embolic microspheres and drug-loaded embolic microspheres. Compared with blank embolic microspheres, drug-loaded embolic microspheres can achieve dense embolization of tumor blood vessels, completely cut off the blood oxygen supply of the tumor to "starve" the tumor, and release the loaded drugs near the tumor to "kill" the tumor and accelerate tumor cell apoptosis. However, most of the drug-loaded microspheres currently produced are smooth solid microspheres. This type of microsphere has a small specific surface area and the drug is loaded on the surface of the microspheres. Therefore, there are defects such as low drug loading and fast drug release rate; in addition, most microspheres are prepared by stirring. The microspheres prepared by this method are uneven in size and have a wide size distribution range. During embolization, these microspheres have the disadvantages of easy tube blockage, formation of embolic gaps, and delayed judgment of the embolic endpoint.

[0004] In the prior art, such as the invention patent application with publication number "CN114470308A" and titled "A Preparation Process for Macroporous Sodium Polyacrylate Embolic Microspheres" published on May 13, 2022, discloses a method for preparing sodium polyacrylate embolic microspheres. The prepared product is a microsphere with pores, which can increase the specific surface area of ​​the microspheres to a certain extent, and increase the drug loading capacity compared with smooth microspheres. However, for sodium polyacrylate embolic microspheres, the method of increasing the drug loading capacity is limited to physical adsorption of the porous structure, and there are still problems of drug desorption and burst release after drug loading. Summary of the invention

[0005] The purpose of the present invention is to provide a porous structure polyacrylic acid drug-loaded embolic microsphere and a preparation method of the embolic microsphere. The obtained polyacrylic acid drug-loaded embolic microsphere is rich in porous structure and a large number of -COOH acidic groups. The porous structure can increase the specific surface area of ​​the microsphere to increase the drug loading amount. At the same time, a large number of -COOH groups can be combined with anti-tumor drugs to reduce the problems of desorption and burst release of the loaded drugs. The embolic microspheres have uniform shapes and controllable microsphere specifications. At the same time, the preparation method is simple in steps, less introduced substances, and less waste of raw materials.

[0006] The present invention is achieved through the following technical solutions:

[0007] A method for preparing porous polyacrylic acid drug-loaded embolic microspheres comprises the following steps:

[0008] a. dissolving acrylic acid or polyacrylic acid, an initiator, a crosslinking agent and a porogen in water to prepare an internal phase solution,

[0009] The mass volume percentage concentration of the acrylic acid or polyacrylic acid is 1.0% to 20% g / mL; the mass volume percentage concentration of the initiator is 0.05% to 5% g / mL; the mass volume percentage concentration of the cross-linking agent is 0.05% to 5% g / mL; the mass volume percentage concentration of the porogen is 0.1% to 10% g / mL, and the porogen is one or more of sodium dodecyl sulfate, sodium dodecyl sulfonate, polyvinyl alcohol, polyethylene glycol, and sodium carboxymethyl cellulose;

[0010] b. dissolving the surfactant in the oil phase to obtain an external phase solution;

[0011] c. The inner phase solution in step a and the outer phase solution in step b are made into acrylic acid or polyacrylic acid droplets through a microfluidic device, and then the droplets are sent to an oil phase at 55 to 110° C. for cross-linking. After the cross-linking is completed, the upper oil phase solution is removed to obtain a primary microsphere product;

[0012] d. The microspheres in step c are then washed and dried to obtain porous polyacrylic acid drug-loaded embolic microspheres.

[0013] Furthermore, the initiator is one of ammonium persulfate and potassium persulfate.

[0014] Furthermore, the cross-linking agent is N, N-methylenebisacrylamide.

[0015] Furthermore, the surfactant in step b is one of Span80, Span85, Tween80, and PGPR, and the concentration of the surfactant is 1%~10%wt.

[0016] Furthermore, the oil phase is selected from one of soybean oil, peanut oil, rapeseed oil and sesame oil.

[0017] Furthermore, in step c, the microfluidic device is a primary microfluidic device, which includes an inlet tube, a connecting tube and a receiving tube. The inner phase solution enters through the inlet tube and the outer phase solution enters through the connecting tube. Droplets are sheared in the microfluidic device, and the droplets are then sent to the oil phase solution through the receiving tube for cross-linking.

[0018] Furthermore, the flow rate of the inner phase solution is 2.5~500 μL / min, and the flow rate of the outer phase is 100~1000 μL / min.

[0019] Furthermore, in the step d, the primary microspheres are washed by a multi-stage washing method, and the washing agents used in the multi-stage washing method are isopropanol, ethanol and deionized water in sequence.

[0020] A porous drug-loaded embolic microsphere is provided, which is a porous polyacrylic acid drug-loaded embolic microsphere obtained by the above-mentioned preparation method.

[0021] The invention discloses an application of the drug-loaded embolic microspheres prepared by the above method in the interventional treatment materials of doxorubicin, epirubicin, irinotecan, cisplatin, methotrexate, mitomycin, carboplatin, decitabine, fluorouracil, gemcitabine, paclitaxel, pirarubicin, larotrectinib, lenvatinib, sunitinib and gefitinib in the process of tumor treatment.

[0022] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0023] 1. In the present invention, the polyacrylic acid drug-loaded embolic microspheres obtained by the preparation method of the present invention have a porous structure, which can achieve rapid loading and slow release of drugs, and have a higher drug loading capacity than smooth embolic microspheres.

[0024] 2. In the present invention, acrylic acid or polyacrylic acid is used as a raw material substrate to prepare polyacrylic acid drug-loaded embolic microspheres, and sodium acrylate or sodium polyacrylate is no longer used as a raw material substrate, so that the prepared drug-loaded embolic microspheres are rich in a large number of -COOH groups. The -COOH groups can combine with the positively charged functional groups of the drug-loaded objects, thereby significantly increasing the drug loading capacity of the embolic microspheres. In addition, by adopting the preparation method of the present invention, other reagents that destroy the -COOH groups (i.e., reagents that react with the -COOH groups) are not introduced, and the -COOH groups can be retained as much as possible to obtain embolic microspheres with a high drug loading capacity.

[0025] 3. In the present invention, due to the presence of -COOH groups in the polyacrylic acid drug-loaded embolic microspheres, the binding rate of the microspheres with positively charged drugs will be significantly increased under the action of electrostatic adsorption, thereby also improving the drug loading rate of the microspheres and reducing the desorption and burst release of drugs from the drug-loaded embolic microspheres.

[0026] Fourth, in the present invention, the embolic microspheres are prepared by using a microfluidic device. The obtained embolic microspheres have uniform shape and controllable particle size. The particle size distribution range of the products in the same batch is narrow, and the waste of raw materials can be avoided. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 It is a schematic diagram of the structure of a first-level microfluidic device.

[0028] Figure 2 This is a scanning electron microscope image of the porous polyacrylic acid drug-loaded embolic microspheres prepared in Example 2.

[0029] Figure 3 yes Figure 2 A higher magnification scanning electron micrograph of the embolic microspheres.

[0030] Figure 4 This is a scanning electron microscope image of the porous polyacrylic acid drug-loaded embolic microspheres prepared in Example 3.

[0031] Figure 5 yes Figure 4 A higher magnification scanning electron micrograph of the embolic microspheres.

[0032] Figure 6 It is a drug loading rate curve diagram of the drug loading test of the embolic microspheres in Example 2.

[0033] Figure 7 This is a drug release rate curve of the embolic microspheres in Example 2. DETAILED DESCRIPTION

[0034] The following examples further illustrate the preparation method of a porous structure polyacrylic acid drug-loaded embolic microsphere provided by the present invention. It is necessary to point out that the following examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Those skilled in the art can make some non-essential improvements and adjustments to the present invention according to the above invention content and implement them specifically, which still falls within the scope of protection of the present invention.

[0035] The structural schematic diagram of the primary capillary microfluidic device used in the following embodiments is as follows: Figure 1 As shown, it includes an inlet tube, a connecting tube and a receiving tube, and also includes a syringe pump. When the primary microfluidic device is used to prepare embolic microspheres, the inner phase solution is introduced into the device from the inlet tube using a syringe pump, and the outer phase solution is introduced into the device from the connecting tube using a syringe pump. Figure 1 The inner phase solution forms droplets under the "shear" action of the outer phase solution, and the droplets are sent to the oil phase through the receiving tube for cross-linking. The receiving tube also contains the oil phase, which makes it easy for the oil phase to take away the droplets. On the other hand, the droplets move in an orderly manner in the receiving tube, achieving the effect of pre-cross-linking, which helps to form embolic microspheres with uniform specifications.

[0036] In the present invention, taking into account factors such as the viscosity of the internal and external phases, the flow rate of the internal phase solution is controlled within the range of 2.5-500 μL / min, the flow rate of the external phase is controlled within the range of 100-1000 μL / min, the cone size is designed to be 40-700 μm, and the receiving tube can be a round tube or a square tube with an equivalent inner diameter of 100-1000 μm, which is helpful for the preparation of embolic microspheres of different sizes.

[0037] In the present invention, considering that the use of multiple porogens may cause uneven void sizes on the microspheres, thus affecting the drug loading effect, the following examples all use only one porogen to prepare polyacrylic acid drug-loaded embolic microspheres.

[0038] Example 1

[0039] In this embodiment, a method for preparing porous polyacrylic acid drug-loaded embolic microspheres comprises the following steps:

[0040] (1) Dissolve acrylic acid or polyacrylic acid, ammonium persulfate, N, N-methylenebisacrylamide and PEG in water to prepare an inner phase solution, wherein the mass volume percentage concentration of acrylic acid or polyacrylic acid is 1.0% g / mL, the mass volume percentage concentration of ammonium persulfate is 0.05% g / mL, the mass volume percentage concentration of N, N-methylenebisacrylamide is 0.05% g / mL, and the mass volume percentage concentration of PEG is 0.1% g / mL;

[0041] (2) Dissolving the surfactant Span80 in the oil phase to obtain an external phase solution, wherein the oil phase is peanut oil and the concentration of the surfactant Span80 is 1% wt;

[0042] (3) Using a microfluidic device, the inner phase solution and the outer phase solution are made into acrylic acid or polyacrylic acid mixed droplets, wherein the inner phase flow rate is 2.5 μL / min, the outer phase flow rate is 40 μL / min, and the equivalent inner diameter of the receiving tube is 100 μm. The droplets are introduced into a 55°C receiving phase for crosslinking, wherein the receiving phase is peanut oil, and further crosslinked. After the crosslinking is completed, the upper oil phase solution is removed to obtain the initial microspheres;

[0043] (4) The microspheres prepared in step (3) are washed with isopropanol, ethanol and deionized water in sequence and freeze-dried to obtain embolic microspheres Q1 with a porous structure.

[0044] Example 2

[0045] In this embodiment, a method for preparing porous polyacrylic acid drug-loaded embolic microspheres comprises the following steps:

[0046] (1) Dissolve acrylic acid or polyacrylic acid, potassium persulfate, N, N-methylenebisacrylamide and sodium dodecyl sulfate in water to prepare an internal phase solution, wherein the mass volume percentage concentration of acrylic acid or polyacrylic acid is 20% g / mL, the mass volume percentage concentration of potassium persulfate is 5% g / mL, the mass volume percentage concentration of N, N-methylenebisacrylamide is 5% g / mL, and the mass volume percentage concentration of sodium dodecyl sulfate is 10% g / mL;

[0047] (2) dissolving the surfactant PGPR in the oil phase to obtain an external phase solution, wherein the oil phase is soybean oil and the concentration of the surfactant PGPR is 5% wt;

[0048] (3) Using a microfluidic device, the inner phase solution and the outer phase solution are made into acrylic acid or polyacrylic acid mixed droplets, wherein the inner phase flow rate is 150 μL / min, the outer phase flow rate is 500 μL / min, and the equivalent inner diameter of the receiving tube is 700 μm. The droplets are introduced into a receiving phase at 110°C for cross-linking, wherein the receiving phase is soybean oil, and further cross-linking is performed. After the cross-linking is completed, the upper oil phase solution is removed to obtain the initial microspheres;

[0049] (4) The microspheres prepared in step (3) are washed with isopropanol, ethanol and deionized water in sequence and then freeze-dried to obtain embolic microspheres Q2 with a porous structure.

[0050] Example 3

[0051] This embodiment is another method for preparing porous polyacrylic acid drug-loaded embolic microspheres, the steps are as follows:

[0052] (1) Dissolve acrylic acid or polyacrylic acid, potassium persulfate, N, N-methylenebisacrylamide and sodium dodecyl sulfate in water to prepare an internal phase solution, wherein the mass volume percentage concentration of acrylic acid or polyacrylic acid is 10% g / mL, the mass volume percentage concentration of potassium persulfate is 1% g / mL, the mass volume percentage concentration of N, N-methylenebisacrylamide is 1% g / mL, and the mass volume percentage concentration of sodium dodecyl sulfate is 5% g / mL;

[0053] (2) Dissolving the surfactant Span80 in the oil phase to obtain an external phase solution, wherein the oil phase is soybean oil and the concentration of the surfactant Span80 is 10% wt;

[0054] (3) Using a microfluidic device, the inner phase solution and the outer phase solution are made into acrylic acid or polyacrylic acid mixed droplets, wherein the inner phase flow rate is 500 μL / min, the outer phase flow rate is 1000 μL / min, and the equivalent inner diameter of the receiving tube is 1000 μm; the droplets are introduced into a 95°C receiving phase for crosslinking, wherein the receiving phase is soybean oil, and further crosslinked. After the crosslinking is completed, the upper oil phase solution is removed to obtain a preliminary microsphere product;

[0055] (4) The microspheres prepared in step (3) are washed with isopropanol, ethanol and deionized water in sequence and then freeze-dried to obtain embolic microspheres Q3 with a porous structure.

[0056] In Examples 4-13, the preparation method of Example 2 was used, and the parameters such as the flow rate of the inner and outer phases, the cone size, and the equivalent inner diameter of the receiving tube were adjusted according to Table 1 to prepare embolic microspheres of different specifications. The size of the microspheres was observed and characterized by an optical microscope, and the uniformity was expressed by the CV value. The test results of each group of embolic microspheres are shown in Table 2. The calculation formula of the CV value is as follows:

[0057] ,

[0058] in, d is the average diameter of the embolic microspheres, n is the number of samples measured, d i is the diameter of the i-th microsphere. In general, when the CV value is less than 5%, the embolic microspheres are considered to have good monodispersity.

[0059] Table 1

[0060]

[0061] Table 2

[0062]

[0063] It can be seen from Tables 1 and 2 that the porous structure polyacrylic acid drug-loaded embolic microspheres prepared by this scheme are uniform in size. It can be seen from the data of Examples 4 to 13 that embolic microspheres of different particle sizes can be prepared by adjusting the flow rates of the inner and outer phase solutions and the cone size of the microfluidic device, and the prepared polyacrylic acid drug-loaded embolic microspheres of various specifications are uniform in size (CV <5%).

[0064] The embolic microspheres Q1, Q2, and Q3 obtained in Examples 1 to 3 were then tested for drug loading and drug release rate. The test method and test results are as follows.

[0065] In the present invention, the drug loading rate curve of the embolic microspheres is drawn through the drug loading test of the embolic microspheres to characterize the drug loading capacity of the embolic microspheres.

[0066] The calculation method of drug loading is: drug loading = (W1-W2) × V / M, where W1 is the initial drug concentration in normal saline, unit: mg / mL; W2 is the drug concentration measured in normal saline after microspheres are loaded with drugs, unit: mg / mL, V is the initial solution volume, and M is the total mass of microspheres.

[0067] The method for obtaining the drug loading speed curve of embolic microspheres is as follows:

[0068] 100 mg of the porous polyacrylic acid drug-loaded embolic microspheres Q2 obtained in Example 2 were placed in a vial containing 10 mL of doxorubicin solution with a doxorubicin concentration of 50 mg / mL. The solution was divided into 18 groups and slowly shaken on a shaker. At 1 min, 3 min, 5 min, 7 min, 10 min, 15 min, 20 min, 25 min, 30 min, 40 min, 50 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, and 24 h, the solution was taken for drug concentration analysis, the drug loading amount of the microspheres was calculated, and the drug loading rate curve was plotted. The results are shown in Table 1. Figure 6 .

[0069] Depend on Figure 6 It can be seen that the porous structure polyacrylic acid drug-loaded embolic microspheres can complete 94% drug loading of the embolic microspheres within 20 minutes, which shows that the drug loading speed of the embolic microspheres is relatively fast.

[0070] In the present invention, the drug release rate test of the embolic microspheres is conducted to draw a drug release rate curve of the embolic microspheres, so as to characterize the drug release performance of the embolic microspheres.

[0071] The calculation method of drug release rate is: drug release rate = (w×v) / m, where w is the drug concentration in PBS solution, unit: mg / mL, v is the volume of PBS solution, and m is the total mass of microspheres.

[0072] The method for obtaining the drug release rate curve of embolic microspheres is as follows:

[0073] (1) 100 mg of the porous polyacrylic acid drug-loaded embolic microspheres obtained in Example 2 were placed in a vial containing 10 mL of a 50 mg / mL doxorubicin solution (21 groups in total), and the vial containing the embolic microspheres and the doxorubicin solution was placed on a shaker for slow shaking. After 24 hours, the microspheres loaded with doxorubicin were filtered out;

[0074] (2) Add the microspheres in step (1) into a vial containing 10 mL of PBS solution, and then take the solution at 1 min, 3 min, 5 min, 7 min, 10 min, 15 min, 20 min, 25 min, 30 min, 40 min, 50 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, 48 h, 72 h, and 168 h for drug concentration analysis and plot the drug release rate curve. The results are referenced to Figure 7 .

[0075] Depend on Figure 7It can be seen that the release rate of embolic microspheres is relatively fast in the first 2 hours, which is mainly because the drugs physically adsorbed on the surface of the microspheres are more likely to desorb and thus quickly released into the solution; and then the drug release slows down, which is mainly because the drugs in the pores of the embolic microspheres are replaced with ions in the PBS solution, and then diffused and released into the solution through the concentration gradient, but compared with the drugs on the surface of the microspheres, the replacement process between the drugs in the pores and the ions in the solution is more difficult, so the drug diffusion release rate is relatively slow, thus achieving slow drug release. This can significantly improve the problem of drug burst release after embolic microspheres are loaded with drugs.

[0076] In addition, by Figure 7 It can be seen that there is a continuous drug release process within 168 hours in the embolic microspheres, so the drug concentration in the tumor site can be maintained at a certain level, thereby achieving a continuous "toxic" effect on the tumor. This also significantly improves the problem of drug desorption and burst release after existing microspheres such as sodium polyacrylate are loaded with drugs, thereby solving the problem of unsatisfactory treatment effects caused by rapid drug desorption and burst release.

[0077] Depend on Figure 6 , 7 It can be seen that the embolic microspheres with an average particle size of 600 μm prepared in Example 2 of the present invention have a drug loading of about 0.47 mg / mg (i.e., 470 mg / g). Compared with the technical solution of Example 1 of "A Process for Preparing Macroporous Sodium Polyacrylate Embolic Microspheres" with publication number "CN114470308A" (when the average particle size of the microspheres is 655 μm, the doxorubicin loading is 53.3 mg / g), the drug loading of the embolic microspheres obtained by this technical solution is significantly higher than the drug loading of the existing macroporous sodium polyacrylate embolic microspheres.

[0078] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any simple modification or equivalent change made to the above embodiment based on the technical essence of the present invention shall fall within the protection scope of the present invention.

Claims

1. A method for preparing porous polyacrylic acid drug-loaded embolic microspheres, characterized in that: The steps include: a. dissolving acrylic acid or polyacrylic acid, an initiator, a crosslinking agent and a porogen in water to prepare an internal phase solution; The mass volume percentage concentration of the acrylic acid or polyacrylic acid is 1.0% to 20% g / mL; the mass volume percentage concentration of the initiator is 0.05% to 5% g / mL; the mass volume percentage concentration of the cross-linking agent is 0.05% to 5% g / mL; the mass volume percentage concentration of the porogen is 0.1% to 10% g / mL, and the porogen is one or more of sodium dodecyl sulfate, sodium dodecyl sulfonate, polyethylene glycol, and sodium carboxymethyl cellulose; b. dissolving the surfactant in the oil phase to obtain an external phase solution; c. The inner phase solution in step a and the outer phase solution in step b are made into acrylic acid or polyacrylic acid droplets through a microfluidic device, and then the droplets are sent to an oil phase at 55 to 110° C. for cross-linking. After the cross-linking is completed, the upper oil phase solution is removed to obtain a primary microsphere product; d. The microspheres in step c are then washed and dried to obtain porous polyacrylic acid drug-loaded embolic microspheres; In step c, the microfluidic device is a primary microfluidic device, which includes an inlet tube, a connecting tube and a receiving tube. The inner phase solution enters through the inlet tube, and the outer phase solution enters through the connecting tube. Droplets are sheared in the microfluidic device, and the droplets are then sent to the oil phase solution through the receiving tube for cross-linking; In step d, the microspheres are washed in a multi-stage washing method, wherein the washing agents used in the multi-stage washing method are isopropanol, ethanol and deionized water in sequence; The flow rate of the inner phase solution is 2.5 to 500 μL / min, and the flow rate of the outer phase is 100 to 1000 μL / min.

2. The method for preparing a porous polyacrylic acid drug-loaded embolic microsphere according to claim 1, characterized in that: The initiator is one of ammonium persulfate and potassium persulfate.

3. The method for preparing a porous polyacrylic acid drug-loaded embolic microsphere according to claim 1, characterized in that: The cross-linking agent is N,N-methylenebisacrylamide.

4. The method for preparing porous polyacrylic acid drug-loaded embolic microspheres according to claim 1, characterized in that: The surfactant in step b is one of Span80, Span85, Tween80 and PGPR, and the concentration of the surfactant is 1% to 10%wt.

5. The method for preparing porous polyacrylic acid drug-loaded embolic microspheres according to claim 1, characterized in that: The oil phase is selected from soybean oil, peanut oil, rapeseed oil and sesame oil.

6. A porous drug-loaded embolic microsphere, characterized in that: The porous polyacrylic acid drug-loaded embolic microspheres are obtained by the preparation method according to any one of claims 1 to 5.